Author

Dania Shaban

McGill University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Anastasia NijnikiD· 2 shared Bianca Pozzebon· 1 shared Danielle MaloiD· 1 shared David LanglaisiD· 1 shared Francis Robert· 1 shared Inés ColmegnaiD· 1 shared Johanna M Toth· 1 shared Joo Eun Kim· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Anastasia NijnikORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Increased Expression and Altered Functional Activities of Immune Receptors TREM1, PD-L1, and Others on Hematopoietic Progenitor Cells in a Mouse Model of Rheumatoid Arthritis

Johanna M Toth, Roselyn R. Jiang, Lin Tze Tung, Dania Shaban, Mathieu Mancini, Bianca Pozzebon, Joo Eun Kim, Mitra Yousefi, Danielle Malo, Silvia Marina Vidal, Inés Colmegna, David Langlais, Anastasia Nijnik

This study shows that immune receptors on hematopoietic progenitor cells are upregulated in a mouse model of rheumatoid arthritis and that stimulating these receptors alters cell expansion and differentiation.

bioRxiv · Jun 12, 2026 · PreprintImmunology

Loss of MYSM1 deubiquitinase catalytic activity protects against MYC-driven B cell lymphoma via tumor intrinsic effects and indirect modulation of antitumor immunity

Dania Shaban, Viktoria Plackoska, Yue Liang, Nay Najm, Francis Robert, Sidong Huang, Anastasia Nijnik

This study shows that inhibiting MYSM1's deubiquitinase activity protects against MYC-driven B cell lymphoma through both tumor intrinsic effects and modulation of antitumor immunity.

bioRxiv · Jan 20, 2026 · PreprintCancer Biology